4.7 Article

HDL activation of endothelial sphingosine-1-phosphate receptor-1 (S1P1) promotes regeneration and suppresses fibrosis in the liver

Journal

JCI INSIGHT
Volume 1, Issue 21, Pages -

Publisher

AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/jci.insight.87058

Keywords

-

Funding

  1. National Heart, Lung, and Blood Institute [R01HL089934, R37 HL067330, R01HL130826, R01HL097797, R01HL119872]
  2. Ansary Stem Cell Institute, National Scientist Development Grant from the American Heart Association [12SDG1213004]
  3. Key National Research and Development Program focused on Stem Cell and Translational Research [2016YFA0101600]
  4. Ministry of Science and Technology, China
  5. Empire State Stem Cell Board and New York State Department of Health [C024180, C026438, C026878, C028117]
  6. Novonordisk foundation [NNF13OC0003898]
  7. National Institute of Health [R01AI085166]
  8. Novo Nordisk Fonden [NNF13OC0003898] Funding Source: researchfish

Ask authors/readers for more resources

Regeneration of hepatic sinusoidal vasculature is essential for non-fibrotic liver regrowth and restoration of its metabolic capacity. However, little is known about how this specialized vascular niche is regenerated. Here we show that activation of endothelial sphingosine-1-phosphate receptor-1 (S1P 1) by its natural ligand bound to HDL (HDL-S1P) induces liver regeneration and curtails fibrosis. In mice lacking HDL-S1P, liver regeneration after partial hepatectomy was impeded and associated with aberrant vascular remodeling, thrombosis and peri-sinusoidal fibrosis. Notably, this maladaptive repair phenotype was recapitulated in mice that lack S1P 1 in the endothelium. Reciprocally, enhanced plasma levels of HDL-S1P or administration of SEW2871, a pharmacological agonist specific for S1P 1 enhanced regeneration of metabolically functional vasculature and alleviated fibrosis in mouse chronic injury and cholestasis models. This study shows that natural and pharmacological ligands modulate endothelial S1P 1 to stimulate liver regeneration and inhibit fibrosis, suggesting that activation of this pathway may be a novel therapeutic strategy for liver fibrosis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available